Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgen Effects on Reproductive Neuroendocrine Axis in Transgender Men
NCT06450405Phase 4Terminated
- Sponsor
- University of California, San Diego
- Start
- Feb 2025
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone cypionate in gender dysphoria (GD), sponsored by University of California, San Diego. Started Feb 2025; status: terminated.
02
Drugs
testosterone cypionate
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT06450405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06450405.